Scientists have discovered the ability to “personalize” cancer treatments using the most modern genetic technology – but experts fear that the secretary for health and human services, Robert F. Kennedy, Jr. In this area of medicine, the latest funding cuts will have a “profound relaxed effect” on the US progress.
The new MRNA vaccines are specially developed to maintain the genetic differences of every patient with stomach cancer, said Japanese researchers in a study published on Tuesday that makes them more effective than standard treatments.
However, vaccine experts told The independent These cuts of 500 million US dollars in the development of MRNA at Emory University, Pfizer and other institutions in flu, covid and infectious disease vaccines could be devastating to make progress in the USA
“The decision of the secretary Kennedy to terminate contracts of 500 million US dollars and to spread lies about the security and protection of mRNA vaccines will have a profound effect on innovative medical research” The independent In an e -mail.
“MRNA vaccines promise enormously not only to protect us from some of the worst infections, but also from devastating diseases such as cancer,” she added. “Instead of looking forward to the promise of life -saving remedies, the secretary would prefer that we look back into the dark times when these diseases devastated.”

MRNA vaccines work differently than conventional vaccines that inject a weakened virus to the body to trigger an immune response. Instead, MRNA vaccines teach the body’s cells to make small and harmless pieces of viruses that trigger the same reaction.
The only MRNA vaccines currently available are Covid vaccines, but cancer vaccines work by attacking the disease. The new vaccines described in the Japanese study use this technology and promote them by aiming for unique places on tumors.
Last week Kennedy said that he would take some MRNA vaccine development and said that the Department of Health and Human Services “changed this financing for safer, wider vaccine platforms that remain effective even if viruses mutated”.
Kennedy, a long -standing vaccine skeptic, has distributed the misinformation that MRNA -Kovid vaccines are fatal and that vaccines “poisoned” despite decades of public research and countless state evaluations.
HHS’s MRNA cuts have not affected cancer vaccine research, which is underway on Baylor College of Medicine and other medical facilities based in Texas, Dr. Peter Hodez, a vaccine scientist and pediatrician at the school. Baylor had announced that the effectiveness of personalized mRNA vaccines were tested in 2023.
However, the financing cuts and denunctions of the technology can influence the field in general.
“It is therefore important that the Federal Government and the Ministry of Health and Human Services reverse their position to MRNA vaccines and throw their support behind this technology,” said Hotez.
Dr. Paul Offit, a vaccine expert at the children’s hospital in Philadelphia, toldThe independent This mRNA research in the fight against cancer is “critical”.
“It is tragic that we have included this in politics, which will only hurt our ability to get forward,” he said.
HHS told The independent It said that the latest cuts of $ 500 million in covid, flu and infectious diseases -MRNA vaccines would not influence any other medical research in the region.

“Technologies that have been financed during the emergency phase but do not meet the current scientific standards are equipped in favor of evidence-based, ethically sound solutions, as to which vaccines of the entire virus and new platforms. Other uses of mRNA technology within the department are not affected by this announcement,” said presseminister Emily Hilliard in an email.
The new study by Kindai University in Osaka explains that the vaccine aims to aim the unique biological signatures of the tumor cells of the individual patients.
“Neoags, which are derived from individual genetic changes in every cancer patient, serve as unique immunological goals for tumor cells and represent the key to personalized immunotherapy,” said the professor of the University of Kindai University, Kazuhiro Kakimi.
The mRNA vaccine helps the body to produce more cancer-related white blood cells and caused tumors shrink or disappear. When using a nameless cancer drug, it had an increased influence on combating the tumor, as the study found.
The Japanese researchers said that the vaccine was particularly effective in peritoneal metastasis, the disease when stomach cancer spreads to the lining of the abdomen. It is one of the most common forms of recurring cancer after surgery in stomach cancer.
Gastric cancer is one of the main causes of cancer deaths in the world. According to the American Cancer Society, 30,300 new cases of stomach cancer and 10,780 deaths will be found in the USA this year. It affects men disproportionately with more than 2,000 deaths than women.